JENNIFER CARDER: Open Payments
NPI 1851139018 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 99 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $330 · 2025 $2,038
Food & beverage: $2,038
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $422 |
| AstraZeneca Pharmaceuticals LP | 20 | $373 |
| Actelion Pharmaceuticals US, Inc. | 6 | $229 |
| GENZYME CORPORATION | 11 | $173 |
| Regeneron Healthcare Solutions, Inc. | 12 | $138 |
| Mallinckrodt Hospital Products Inc. | 5 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90 |
| United Therapeutics Corporation | 3 | $75 |
| Insmed, Inc. | 3 | $75 |
| Merck Sharp & Dohme LLC | 3 | $74 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, UPTRAVI, ACTHAR, BREZTRI, FASENRA, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
